Literature DB >> 14769832

Signal transduction underlying carbachol-induced contraction of human urinary bladder.

Tim Schneider1, Charlotte Fetscher, Susanne Krege, Martin C Michel.   

Abstract

The present study was designed to reexamine the muscarinic acetylcholine receptor subtype mediating carbachol-induced contraction of human urinary bladder and to investigate the underlying signal transduction. Based upon the nonselective tolterodine, the highly M(2)-selective (R)-4-[2-[3-(4-methoxy-benzoylamino)-benzyl]-piperidin-1-ylmethyl]piperidine-1-carboxylic acid amide (Ro-320-6206), and the highly M(3)-selective darifenacin and 3-(1-carbamoyl-1,1-diphenylmethyl)-1-(4-methoxyphenylethyl)pyrrolidine (APP), contraction occurs via M(3) receptors. The phospholipase C inhibitor 1-(6-[([17beta]-3-methoxyestra-1,3,5[10]-trien-17-yl)amino]hexyl)-1H-pyrrole-2,5-dione (U 73,122) (1-10 microM) did not significantly affect carbachol-stimulated bladder contraction. The phospholipase D inhibitor butan-1-ol relative to its negative control butan-2-ol (0.3% each) caused small but detectable inhibition of carbachol-induced bladder contraction. The Ca(2+) entry blocker nifedipine (10-100 nM) strongly inhibited carbachol-induced bladder contraction. In contrast, 1-[beta-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole HCl (SK&F 96,365) (1-10 microM), an inhibitor of store-operated Ca(2+) channels, caused little inhibition. The protein kinase C inhibitor bisindolylmaleimide I (1-10 microM) did not significantly affected carbachol-induced bladder contraction. In contrast, trans-4-[(1R)-1-aminoethyl]-N-4-pyridinylcyclohexanecarboxamide (Y 27,632) (1-10 microM), an inhibitor of rho-associated kinases, concentration dependently and effectively attenuated the carbachol responses. We conclude that carbachol-induced contraction of human urinary bladder via M(3) receptors largely depends on Ca(2+) entry through nifedipine-sensitive channels and activation of a rho kinase, whereas phospholipase D and store-operated Ca(2+) channels contribute only in a minor way. Surprisingly, phospholipase C or protein kinase C do not seem to be involved to a relevant extent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769832     DOI: 10.1124/jpet.103.063735

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

1.  Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.

Authors:  Yasuhiko Igawa; Tim Schneider; Yoshinobu Yamazaki; Satoshi Tatemichi; Yukio Homma; Osamu Nishizawa; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-29       Impact factor: 3.000

Review 2.  Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction.

Authors:  George J Christ; Steve Hodges
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Muscarinic receptor expression and receptor-mediated detrusor contraction: comparison of juvenile and adult porcine tissue.

Authors:  Melinda Wuest; Birgit Eichhorn; Manfred Braeter; Gerhard Strugala; Martin C Michel; Ursula Ravens
Journal:  Pflugers Arch       Date:  2007-12-21       Impact factor: 3.657

4.  Large-conductance voltage- and Ca2+-activated K+ channel regulation by protein kinase C in guinea pig urinary bladder smooth muscle.

Authors:  Kiril L Hristov; Amy C Smith; Shankar P Parajuli; John Malysz; Georgi V Petkov
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-18       Impact factor: 4.249

5.  Regulation of bladder muscarinic receptor subtypes by experimental pathologies.

Authors:  M R Ruggieri; A S Braverman
Journal:  Auton Autacoid Pharmacol       Date:  2006-07

6.  Age-dependent contribution of Rho kinase in carbachol-induced contraction of human detrusor smooth muscle in vitro.

Authors:  Timo Kirschstein; Chris Protzel; Katrin Porath; Tina Sellmann; Rüdiger Köhling; Oliver W Hakenberg
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

7.  Anticholinergic effects of cis- and trans-isomers of two metabolites of propiverine.

Authors:  Stefan Propping; Manfred Braeter; Marc-Oliver Grimm; Manfred P Wirth; Ursula Ravens; Melinda Wuest
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-02-25       Impact factor: 3.000

8.  Octodon degus, a new model to study the agonist and plexus-induced response in the urinary bladder.

Authors:  Francisco Eduardo Martin-Cano; Mercedes Caso-Agundez; Cristina Camello-Almaraz; Francisco Juan Santos; María Teresa Espin; Juan Antonio Madrid; Adolfo Diez-Perez; Pedro Javier Camello; Maria Jose Pozo
Journal:  J Physiol Biochem       Date:  2016-10-13       Impact factor: 4.158

9.  Medical management of overactive bladder.

Authors:  Sarvpreet S Ubee; Ramaswamy Manikandan; Gurpreet Singh
Journal:  Indian J Urol       Date:  2010-04

Review 10.  Basic mechanisms of urgency: roles and benefits of pharmacotherapy.

Authors:  Martin Christian Michel; Christopher R Chapple
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.